Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
35.00    1.00 (2.94%)
Bid:
34.00
Ask:
36.00
Spread: 2.00 (5.882%)
Market Cap: £20.76m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

7 Aug 2025 07:00

RNS Number : 3109U
KRM22 PLC
07 August 2025
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Half Year Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company with a particular focus on risk management in capital markets, today issues the following trading update for the six months ended 30 June 2025 (the "Period") which is in line with market expectations.

 

The Company has continued to make good progress in the Period, increasing the value of its Annual Recurring Revenue ("ARR") from £6.6m at the end of FY 2024 to £7.2m at the end of the Period.

 

The Company expects to report results for the Period in September 2025, and these are estimated to be:

· ARR: £7.2m (H1 2024: £6.0m)

· Total revenue recognised: £3.7m (H1 2024: £3.3m)

· Adjusted EBITDA: £0.3m (H1 2024: £0.3m)

· Cash balance as at 30 June 2025: £1.4m (FY 2024: £1.0m)

 

Approximately 50% of Group ARR is derived from USD denominated contracts and, with a 9 per cent change in GBP: USD FX rates in the Period, ARR at the start of the Period restated using a constant FX rate as at Period end was £6.3m (£6.6m as previously reported using 31 December 2024 FX rates). 

 

Using constant exchange rates, the change in ARR during the Period was a net increase of £0.9m. This was driven by £1.0m in new ARR, which came from cross-sales to existing customers and contractual price increases. Specifically, cross-sales of the Risk Manager, Limits Manager, and Market Surveillance applications generated £0.9m, while contractual price increases across the same applications added another £0.1m. This growth was partially offset by a customer churn of £0.1m, which was mainly attributed to a single institutional customer cancelling their subscription to the Market Surveillance application.

 

Since the end of the Period, an additional £0.1m of ARR has been generated through contractual price increases with an existing customer migrating to Risk Manager, on a three year term, from a rolling monthly contract for the legacy At-Trade application. Following industry consolidation, there has been further churn of £0.2m for the Market Surveillance application which, whilst this was anticipated and is disappointing, the customer does continue to use the Limits Manager and Post-Trade applications, with a view to migrating from the legacy Post-Trade application to Risk Manager.

 

Factoring in the aforementioned changes in ARR since the end of the Period, and the continual fluctuation in FX rates, Group ARR at the date of this announcement continues to be £7.2m using 31 July 2025 FX rates (£7.1m using Period end rates). The Company continues to have a strong pipeline of sales opportunities for the Limits Manager and Risk Manager applications which it expects to close by the end of the year to achieve current market expectations.

 

The Company's cash balance at the end of the Period was £1.4m, a net increase in cash of £0.4m since FY 2024. The Company expects to continue to operate within its existing cash and debt facilities; however, the Board continues to remain focused on careful cash management as it enters the second half of the year.

 

Dan Carter, CEO of KRM22, commented: "With £1.0m of new ARR generated in the first half of 2025, primarily from cross sale opportunities, and a substantial pipeline of sales opportunities through the remainder of the year, we are well positioned to continue with progress to becoming a cash generative and profitable business."

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Garry Jones, Non-Executive Chairman

Dan Carter, CEO

Kim Suter, CFO

 

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Stephen Keys / Isaac Hooper (Corporate Finance)

Sunila de Silva (ECM)

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at www.krm22.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSAFWMEISEFA
Date   Source Headline
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSIssue of Options
12th Jan 20217:00 amRNSTrading Update
5th Oct 20207:00 amRNSIssue of Options
21st Sep 20208:33 amRNSIssue of Options
18th Sep 20209:26 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSNew Debt Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.